Table 6. Comparison of the top ten parental antibacterials consumed between sectors.
| Public sector | Private sector | ||||||
|---|---|---|---|---|---|---|---|
| ABM | AWaRe group | DDDs in million | % | ABM | AWaRe group | DDDs in million | % |
| Benzyl penicillin | A | 16.95 | 75.98 | Flucloxacillin | A | 0.35 | 20.57 |
| Co-amoxiclav | A | 2.52 | 11.29 | Ampicillin | A | 0.24 | 14.43 |
| Cefuroxime | W | 1.08 | 4.86 | Ceftriaxone | W | 0.23 | 13.53 |
| Ceftriaxone | W | 0.48 | 2.16 | Cefuroxime | W | 0.21 | 12.39 |
| Meropenem | W | 0.3 | 1.35 | Metronidazole | A | 0.14 | 8.53 |
| Cefotaxime | W | 0.14 | 0.64 | Meropenem | W | 0.12 | 7.26 |
| Cloxacillin | A | 0.14 | 0.62 | Co-amoxiclav | A | 0.12 | 6.92 |
| Flucloxacillin | A | 0.13 | 0.56 | Clarithromycin | W | 0.09 | 5.32 |
| Gentamicin | A | 0.11 | 0.48 | Moxifloxacin | W | 0.04 | 2.27 |
| Levofloxacin | W | 0.09 | 0.38 | Cefotaxime | W | 0.03 | 1.96 |